JP2008545396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545396A5 JP2008545396A5 JP2008512501A JP2008512501A JP2008545396A5 JP 2008545396 A5 JP2008545396 A5 JP 2008545396A5 JP 2008512501 A JP2008512501 A JP 2008512501A JP 2008512501 A JP2008512501 A JP 2008512501A JP 2008545396 A5 JP2008545396 A5 JP 2008545396A5
- Authority
- JP
- Japan
- Prior art keywords
- natural
- cxcr3
- receptor ligand
- ligand
- polypeptide receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003446 ligand Substances 0.000 claims 41
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims 24
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims 24
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 102000040430 polynucleotide Human genes 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 8
- 239000002157 polynucleotide Substances 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 102000005962 receptors Human genes 0.000 claims 5
- 108020003175 receptors Proteins 0.000 claims 5
- 206010016654 Fibrosis Diseases 0.000 claims 4
- 230000004761 fibrosis Effects 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 3
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000004614 tumor growth Effects 0.000 claims 2
- 239000013603 viral vector Substances 0.000 claims 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 229940123237 Taxane Drugs 0.000 claims 1
- 241000863480 Vinca Species 0.000 claims 1
- 229930013930 alkaloid Natural products 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000340 anti-metabolite Effects 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940100197 antimetabolite Drugs 0.000 claims 1
- 239000002256 antimetabolite Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 claims 1
- 230000009787 cardiac fibrosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- -1 nitrosoureas Substances 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 239000003270 steroid hormone Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68254405P | 2005-05-18 | 2005-05-18 | |
| PCT/US2006/019233 WO2006125077A2 (en) | 2005-05-18 | 2006-05-17 | Non-natural chemokine receptor ligands and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545396A JP2008545396A (ja) | 2008-12-18 |
| JP2008545396A5 true JP2008545396A5 (enExample) | 2009-07-02 |
Family
ID=37432131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008512501A Pending JP2008545396A (ja) | 2005-05-18 | 2006-05-17 | 非天然ケモカイン受容体リガンドおよびこれらの使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20090131312A1 (enExample) |
| EP (1) | EP1885386A4 (enExample) |
| JP (1) | JP2008545396A (enExample) |
| WO (1) | WO2006125077A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008149354A2 (en) | 2007-06-04 | 2008-12-11 | Rappaport Family Institute For Research In The Medical Sciences | Agents for the treatment of inflammatory diseases and methods of using same |
| US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| EP2229951A1 (en) | 2009-03-08 | 2010-09-22 | Stichting Katholieke Universiteit | Methods for the treatment or prevention of systemic sclerosis |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| EP2585071A1 (en) * | 2010-06-28 | 2013-05-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical composition for use in the treatment of glaucoma |
| CN102697864B (zh) * | 2012-05-16 | 2013-09-18 | 福州市台江区泽越医药技术有限公司 | 红茂草或其提取物的新用途 |
| JPWO2023120643A1 (enExample) * | 2021-12-23 | 2023-06-29 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977334A (en) * | 1997-09-11 | 1999-11-02 | The Cleveland Clinic Foundation | DNA encoding a chemokine, Beta R1, comprising the Beta R1 promoter |
| US6723538B2 (en) * | 1999-03-11 | 2004-04-20 | Micromet Ag | Bispecific antibody and chemokine receptor constructs |
| ATE359297T1 (de) * | 2002-06-12 | 2007-05-15 | Applied Research Systems | Antagonisten für cxcr3-bindende cxc-chemokine |
| EP1558629A2 (en) * | 2002-09-23 | 2005-08-03 | Rmf Dictagene S.A. | Synthetic chemokines labeled at selected positions |
| CN101039957A (zh) * | 2003-05-16 | 2007-09-19 | 因特缪恩公司 | 合成的趋化因子受体配体及其使用方法 |
-
2006
- 2006-05-17 WO PCT/US2006/019233 patent/WO2006125077A2/en not_active Ceased
- 2006-05-17 JP JP2008512501A patent/JP2008545396A/ja active Pending
- 2006-05-17 US US11/913,768 patent/US20090131312A1/en not_active Abandoned
- 2006-05-17 EP EP06760092A patent/EP1885386A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010068806A5 (enExample) | ||
| US5506208A (en) | Method for using synthetic analogs of thrombospondin for inhibiting angiogenesis activity | |
| JP2007513634A5 (enExample) | ||
| RU2017114414A (ru) | НОВЫЕ АНТАГОНИСТЫ α4β7 НА ОСНОВЕ МОНОМЕРНЫХ И ДИМЕРНЫХ ПЕПТИДОВ | |
| RU2010147076A (ru) | Аналоги инсулина специфичные к изоформам | |
| JP2013027391A5 (enExample) | ||
| JP2018138049A5 (enExample) | ||
| EP0478101B1 (en) | Therapeutic use of peptides having thrombospondin-like activity | |
| JP2009525052A5 (enExample) | ||
| JP2022008516A5 (enExample) | ||
| JP2009529509A5 (enExample) | ||
| JP2011509093A5 (enExample) | ||
| JP2012532601A5 (enExample) | ||
| HRP20221531T1 (hr) | Pripravci faktora viii i postupci dobivanja i korištenja istih | |
| WO2005024039B1 (en) | Improved method for generating influenza viruses and vaccines | |
| RU2017119773A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
| JP2015534568A (ja) | Ｉｒｆ５に結合する細胞透過性ペプチド | |
| JP2008507298A5 (enExample) | ||
| JP2015504052A5 (enExample) | ||
| JP2008545396A5 (enExample) | ||
| JP2019513344A5 (enExample) | ||
| JP2008545393A5 (enExample) | ||
| JP2014504297A5 (enExample) | ||
| JP2006514820A5 (enExample) | ||
| CA2509484A1 (en) | Stabilized immunogenic hbc chimer particles |